HALOZYME THERAPEUTICS, INC. (HALO) /
The debt of HALOZYME THERAPEUTICS, INC. over the past 10 years
Chart HALOZYME THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, HALOZYME THERAPEUTICS, INC. had liquid cash of $142.82M and total debt of $2.14B: net debt of $2B. It had more liquid cash than debt at 3 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($2.14B) and lowest at the end of fiscal 2018 ($126.38M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $142.82M* | $2.14B | -$2B |
| 2024ended Dec 31, 2024 | $596.07M* | $1.51B | -$909.72M |
| 2023ended Dec 31, 2023 | $336M* | $1.5B | -$1.16B |
| 2022ended Dec 31, 2022 | $362.79M* | $1.51B | -$1.14B |
| 2021ended Dec 31, 2021 | $740.92M* | $876.67M | -$135.75M |
| 2020ended Dec 31, 2020 | $368.01M* | $397.23M | -$29.21M |
| 2019ended Dec 31, 2019 | $421.26M* | $402.59M | $18.68M |
| 2018ended Dec 31, 2018 | $354.53M* | $126.38M | $228.15M |
| 2017ended Dec 31, 2017 | $469.21M* | $202.35M | $266.86M |
| 2016ended Dec 31, 2016 | $204.98M* | $216.62M | -$11.64M |
Fiscal years as HALOZYME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on HALOZYME THERAPEUTICS, INC.
- The revenue of HALOZYME THERAPEUTICS, INC.
- The profitability of HALOZYME THERAPEUTICS, INC.
- The cash flow of HALOZYME THERAPEUTICS, INC.
- All of HALOZYME THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- ALLEAllegion plc
- PNFPPINNACLE FINANCIAL PARTNERS, INC.
- JHXJAMES HARDIE INDUSTRIES plc
- SUISUN COMMUNITIES, INC
- BZKANZHUN LIMITED
Not investment advice. This page shows what HALOZYME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.